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Abstract
Background: Mycoplasma pneumoniae pneumonia (MPP) is one of the most common causes of childhood community-acquired 
pneumonia (CAP) and common cause of mortality and morbidity in young children. Polymerase chain reaction (PCR) is promising with 
higher specificity and superior sensitivity to that of culture or single point serology. Objective: This study was conducted to estimate the 
prevalence of MPP, and to compare the efficacy of PCR and immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) 
for the diagnosis of MPP among CAP in children. Materials and Methods: This study was conducted in children between 2 months 
and 12 years of age admitted with clinical and radiological features of pneumonia. The children were presumed clinically to have MP 
infection as per IAP guidelines when they had a cough and fever for more than 5 days. A predesigned proforma was used to collect 
history and clinical examination findings. Routine investigations such as complete blood count, C-reactive protein, chest X-ray, and 
blood culture were done. Those suspected of infection with MP infection were further subjected to PCR and IgM ELISA. Results: MP 
(27%) was found to be an important cause of CAP in children between 2 and 8 years. The most common clinical symptoms were cough 
and fever (100%) followed by myalgia (20.8%), arthralgia (16.6%), and rashes (12.5%). PCR is the rapid reliable diagnostic test with 
a sensitivity of 100% and specificity of 93%. IgM ELISA is equally effective diagnostic test with sensitivity of 83% and specificity of 
100%. Conclusion: MP is an emerging cause of CAP in school going as well as preschool children. Although PCR is an alternative test 
of culture, use of simple test like IgM ELISA will reduce the cost of investigation and help us in arriving at definitive diagnosis of MP.
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M ycoplasma pneumonia (MP) is one of the most common causes of childhood community-acquired pneumonia (CAP) and also the common cause 
of mortality and morbidity in young children [1]. The WHO 
has estimated that annually, pneumonia kills up to 2.4 million 
children, which accounts for 19% of all deaths in under-five age 
group [2]. MP pneumonia (MPP) is a disease of gradual onset 
associated with fever, cough, headache, myalgia, sore throat, and 
other nonspecific symptoms. However, these are not specific 
enough for the diagnosis of MPP in clinical practice. β-lactam 
antibiotics used empirically in the treatment of pneumonia are 
ineffective in these cases. Hence, a rapid diagnostic method is 
required to initiate the appropriate treatment.
Because of the fastidious nature of MP, culture methods are 
relatively insensitive, time-consuming, and expensive [3]. The 
commercially available enzyme-linked immunosorbent assay 
(ELISA) is more specific and sensitive but require paired sera 
for diagnosis [4]. Polymerase chain reaction (PCR) is promising 
with higher specificity and superior sensitivity to that of culture 
or single point serology [5]. Information on diagnostic methods 
used for MP in Indian pediatric population is scarce [6]. Thus, 
this study was conducted to know the prevalence of MP and to 
compare the efficacy of PCR and immunoglobulin M (IgM) 
ELISA for the diagnosis of MPP among CAP infection in 
children.
MATERIALS AND METHODS
This study was conducted at Indira Gandhi Institute of Child 
Health (IGICH), Bangalore, a tertiary care pediatric hospital 
from November 2012 to September 2013. This study was 
approved by the Institutional Ethical Committee. All the 
children in the age group of 2 months to 12 years admitted 
with a diagnosis of pneumonia during the study period were 
enrolled. Diagnosis of pneumonia was made on the basis of 
clinical features of pneumonia as per Integrated Management 
of Neonatal and Childhood Illness Guidelines as well as clinical 
Kumar et al. Validation of IgM for diagnosis of M. pneumoniae pneumonia
Vol 3 | Issue 1 | Jan - Mar 2016 Indian J Child Health 33
criteria and radiological features for children more than 5 years 
as per RTI GEM- IAP and Nelson Text Book of Pediatrics [7]. 
The children less than 2 months of age, who were treated with 
macrolides in the preceding 14 days, children with predisposing 
factors for recurrent pneumonia and with chronic lung disease 
were excluded from the study.
Children were presumed clinically to have MP infection 
as per IAP guidelines when they had cough and fever for 
more than 5 days with or without systemic symptoms such 
as myalgia and arthralgia, hurried breathing and respiratory 
clinical signs predominantly crepitations, rhonchi without 
obvious evidence of localized consolidation. The children 
were enrolled into the study after taking informed consent 
from the parents.
These children after obtaining detailed history were 
examined for signs and symptoms of pneumonia, and evaluated 
for respiratory distress. The oxygen saturation (by pulse 
oximetry) was also noted. Auscultation findings (crepitations, 
wheeze, bronchial breath sounds) were recorded. These children 
were subjected to routine investigations such as complete blood 
count, C-reactive protein (CRP), chest X-ray, and blood culture 
and those suspected of infection with MP were further subjected 
for PCR and IgM ELISA of the same. All Children were given 
standard treatment for pneumonia and those children who were 
positive for MP were treated with Macrolides.
ELISA for IgM
Blood was collected from all the suspected 86 cases with 
clinical features of pneumonia. Serum was separated and 
stored at -20°C and IgM antibody detection was done using 
Nova Tec Immunodiagnostica kit GmbH Germany, according 
to the manufacture’s instruction. It is based on the principle 
that gelatin particles sensitized with membrane components of 
MP strain are agglutinated in the presence of MP antibody and 
mainly measure IgM for MP [8].
PCR Methodology
The test was outsourced and done in NABH accredited 
laboratory. Nasopharyngeal swabs were collected from all 
the clinically suspected MP cases. After DNA extraction, 
specific primers were used for priming and amplification 
which was done in thermocycler. Amplified products were 
subjected for identification (electrophoresis). The presence 
of specific amplification band is matched with a standard 
band of MP.
Statistical Analysis
Descriptive and inferential statistical analysis has been carried 
out in this study. Results on categorical measurements are 
presented in number (%). The significance is assessed at 5% 
level. Chi-square/Fisher exact test has been used to find the 
significance of study parameters on categorical scale between 
two or more groups.
RESULTS
Out of total 568 cases admitted with pneumonia, 86 children 
were clinically suspected of MP. Moreover, out of these 86 cases, 
PCR was positive in 24 cases accounting for the prevalence 
of 4.2% among CAP. In our study, among the cohort of PCR 
confirmed MP, 13 (54%) children were between 2 and 8 years 
of age. There was male preponderance with male to female 
ratio of 1.4:1 (Table 1).
We found that all the children had cough, fever, and 
crepitations. About 45% of these children had hurried breathing 
and 41% of them had chest retractions. In our cohort of PCR 
positive MP, anemia was seen in 25% of the children and 
serum CRP was elevated in 87.5% cases. The radiological 
findings include reticulonodular infiltrates (62.5%), bilateral 
peribronchial interstitial infiltrates (16.6%), bronchopneumonia 
(12.5%), and nonspecific changes (8.3%) (Table 2).
The IgM for MP was positive in 83% of the children with 
PCR positive MP and none of PCR-negative cases as shown in 
Table 3. The sensitivity and specificity of IgM MP was 83.3% 
(95% confidence interval [CI] - 61.8%-94.5%) and 80.6% 
(95% CI - 68.2%-89.1%), respectively.
DISCUSSION
MP infection is one of the common causes of CAP especially 
in school going children with reported incidence of 15-30%, in 
India [9]. The clinical features are nonspecific and confirmatory 
lab test is PCR which is expensive. Hence, there is need to 
evaluate a simple and cost-effective lab diagnostic test to 
confirm the diagnosis. We studied to validate the IgM for MP 
test to detect the MPP.
In our study, the most common age group affected by MPP 
was 2-8 years (54.1%) which was in concordance with study 
conducted by Shenoy et al. [9], Ramamoorthy et al. [10], and 
Waris et al. [11]. Although in previous studies MPP is found 
to be common in school age group, the present study has 
Table 1: Baseline data
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shown that there is a changing trend of MPP involving even the 
preschool age group.
In our study, common clinical presentations were cough 
and fever (100%), and extrapulmonary symptoms such as 
myalgia (20.8%), arthralgia (16.6%), and rashes (12.5%). This 
was similar to the study done by Kashyap et al., where fever 
(100%), cough (100%), and tachypnea (37.2%) were main 
clinical presentations. The common respiratory signs were 
crepitations (100%), retractions (41.6%), and rhonchi (16.6%). 
Kashyap et al., [6] also showed scattered crepitations (78.67%) 
and rhonchi (37.32%) as the predominant signs. Radiological 
features found in our study cohort were similar to that shown in 
a study by Kashyap et al. [6].
Although culture is the gold standard test to confirm MP 
infection, culture is tedious and difficult to grow the organism. 
Hence, PCR has been taken as the gold standard method to 
confirm the diagnosis of MPP [12]. It is time saving and has 
high sensitivity and specificity as shown in previous studies 
by Kashyap et al., [6] and Nadala et al. [13]. In our study, PCR 
was positive in 24 (27.9%) clinically suspected cases which 
was similar to the observations made by Sidal et al., [14]
and Blackmore et al., [15] who found MP PCR positive 
in 33 (16.2%) and 25 (25%) cases, respectively. The sensitivity 
and specificity of PCR were 92% and 98%, respectively, in the 
study by Blackmore et al., [15]and they concluded that PCR 
appeared to have advantages over serological testing, both with 
respect to accuracy and convenience of single specimen testing.
In the present study, IgM antibody was positive 
in 20 (23.9%) out of 86 children with suspected MPP which was 
in concordance to study done Chaudhry et al. [16]. They found 
serological evidence of MP in 17 (27.4%) out of 62 children 
based on microparticle agglutination test for IgM antibodies 
and indirect immunofluorescence test for antigen detection 
from throat swabs. Similarly, Pandey et al., [17] showed IgM 
positivity for MP in 21 (30%) out of 70 children. In a study by 
Ramamoorthi et al. [10], culture and IgM antibody positivity 
for MP were 10.5% and 31.5%, respectively. They showed 
that the diagnosis of MPP may be made routinely in clinical 
microbiology units using IgM ELISA; however, IgM ELISA 
was less sensitive in very early infection as compared to PCR.
In our study, 20 (23.9%) out of 86 cases were positive by 
IgM ELISA with sensitivity of 83% and specificity of 80.6%. 
Waris et al., [11] showed that, 24 out of 24 MPP children 
(sensitivity, 100%) were positive by IgM-capture test with 
convalescent phase serum, 19 (79%) were positive by the 
IgM- capture test with acute phase serum, 19 (79%) were 
positive by IgG serology, 10 (41.6%) were positive by PCR 
and 8 of 17 (47%) were positive by culture. They concluded 
that IgM serology test was the single most valuable tool for the 
diagnosis of MPP in children of any age.
The detection of MP in symptomatic children by specific IgM 
detections was the optimum approach for the diagnosis in our 
study. The advantage of this being easy and early diagnosis of 
MPP so as to decrease the duration of hospital stay as well as cost 
of treatment considerably using simple antibiotics like macrolides 
and avoiding unnecessary inappropriate irrational antibiotic 
usage. However, our study was limited by small sample size and 
it needs a larger group to arrive at a definitive conclusion.
CONCLUSION
The prevalence of MP among CAP was 4.2%, and the majority 
of them was in children between 2 and 8 years of age. The 
sensitivity and specificity of IgM for MP was 83.3% and 
80.6%, respectively. For optimal diagnosis and timely initiation 
of therapy, the combination of clinical features, PCR and IgM 
for MP may be more beneficial.




Hurried breathing 11 45







Chest pain 01 4.6
Lab parameters
Hb% <10 g/dl 6 25
Hb% >10 m/dl 18 75
Positive CRP 21 87.5
Radiological findings






Hb: Hemoglobin, CRP: C-reactive protein
Table 3: Correlation of IgM for MP and PCR for MP
IgM PCR (%) Total (%) Chi-square
p valuePositive Negative
Positive 20 (83.3) 0 (0) 20 (23.25) χ2=62.73
p<0.01**Negative 4 (16.7) 62 (100) 66 (76.75)
Total 24 (100.0) 62 (100.0) 86 (100)
IgM: Immunoglobulin M, PCR: Polymerase chain 
reaction, MP: Mycoplasma pneumoniae, ** P value < 0.05 
is significant
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